using medicaid data to map avoidable prescribing practicesfebruary 10, 2019 using medicaid data to...

Post on 25-Mar-2020

4 Views

Category:

Documents

0 Downloads

Preview:

Click to see full reader

TRANSCRIPT

February 10, 2019

Using Medicaid Data to MapAvoidable Prescribing Practices

Emily Lutterloh, MD, MPHDirector, Bureau of Healthcare Associated InfectionsNew York State Department of Health

February 10, 2019 2

https://www.cdc.gov/antibiotic-use/community/images/programs-measurement/Community-antibiotic-map-2015.jpg

February 10, 2019 3

Analysis• Collaboration with NYSDOH Office of Quality and

Patient Safety– Access to and experience with Medicaid data

• Identify initial visits to outpatient providers for acute upper respiratory infections (URIs)

• Use pharmacy claims data to identify visits when an antibiotic was prescribed and subsequently filled

• Determine regional rates of prescribing for URIs to better target interventions

Based on: Li P, Metlay JP, Marcus SC, Doshi JA. Factors associated with antimicrobial drug usein Medicaid programs. Emerg Infect Dis (Internet). 2014; 20(5): 829-832. https://dx.doi.org/10.3201/eid2005.130493

February 10, 2019 4

Analysis• Mapped potentially

avoidable prescribingfor URIs

• Created county-levelmaps based onprovider practicelocation

February 10, 2019 5

Adult Outpatient Antibiotics for Acute URI, 2010 - 2016

February 10, 2019 6

Pediatric Outpatient Antibiotics for Acute URI, 2010 - 2016

February 10, 2019 7

Outreach: Letter to Prescribers• Sent “Dear

Provider” letters and map to providers in 11 high-prescribing counties likely to see patients for URIs

• Followed up with educational materials

February 10, 2019 8

InterventionsAntibiotic Resistance Task Force

February 10, 2019 9

The Future• Next Steps

– Additional years– Other conditions,

e.g. pharyngitis, otitis media

– Overall antibiotic prescribing per Medicaid enrollee

– Assess adherence to guidelines

– Other insurers

• Impact– Target other initiatives– Multiple other initiatives

ongoing simultaneously• Difficult to measure

– Continue to follow as additional yearsof data become available

February 10, 2019 10

Thank You

https://www.cdc.gov/antibiotic-use/community/materials-references/print-materials/hcp/index.html

top related